• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清miR-155和miR-224在中国丙型肝炎病毒感染患者中的表达及临床价值

Expression and Clinical Values of Serum miR-155 and miR-224 in Chinese Patients with HCV Infection.

作者信息

Jin Xiaochun, Zhang Ying, Wang Hui, Zhang Youtao

机构信息

Department of Anesthesiology, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu, People's Republic of China.

Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.

出版信息

Int J Gen Med. 2022 Feb 10;15:1393-1403. doi: 10.2147/IJGM.S344345. eCollection 2022.

DOI:10.2147/IJGM.S344345
PMID:35173476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8843352/
Abstract

BACKGROUND

To investigate the expression of serum miR-155 and miR-224 among patients with hepatitis C virus (HCV) infection and analyze their clinical values.

METHODS

A total of 116 patients suffering from HCV infection admitted to our hospital and 70 healthy subjects were selected. According to the diagnostic results, patients with HCV infection were divided into 48 cases of chronic hepatitis C (CHC), 43 cases of liver cirrhosis and 25 cases of hepatocellular carcinoma (HCC). The expression signature for miR-155 and miR-224 was detected in serum samples. ROC curve and Pearson correlation test were conducted to investigate their diagnostic value and correlation.

RESULTS

The expression extent for serum miR-155 and miR-224 increased along with the increase of malignancy (all P < 0.05). According to ROC curve, the area under the curve (0.918, 95% CI: 0.856-0.974) of miR-155 and miR-224 combined in the diagnosis of HCC was the largest, and its sensitivity and specificity were 93.0% and 86.2%. There is a positive relationship for expression level between miR-155 and miR-224 in CHC and HCC group (all P < 0.001).

CONCLUSION

miR-155 and miR-224 are remarkably increased in patients suffering from HCV infection. The combination of miR-155 and miR-224 has a good diagnostic value for HCC caused by HCV infection.

摘要

背景

探讨丙型肝炎病毒(HCV)感染患者血清miR-155和miR-224的表达情况,并分析其临床价值。

方法

选取我院收治的116例HCV感染患者及70例健康对照者。根据诊断结果,将HCV感染患者分为慢性丙型肝炎(CHC)48例、肝硬化43例和肝细胞癌(HCC)25例。检测血清样本中miR-155和miR-224的表达特征。采用ROC曲线和Pearson相关性检验来研究其诊断价值及相关性。

结果

血清miR-155和miR-224的表达水平随恶性程度增加而升高(均P < 0.05)。根据ROC曲线,miR-155和miR-224联合诊断HCC时曲线下面积最大(0.918,95%CI:0.856 - 0.974),其敏感性和特异性分别为93.0%和86.2%。CHC组和HCC组中miR-155与miR-224的表达水平呈正相关(均P < 0.001)。

结论

HCV感染患者中miR-155和miR-224显著升高。miR-155和miR-224联合检测对HCV感染所致HCC具有良好的诊断价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/5a5c1935b763/IJGM-15-1393-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/3259993451fb/IJGM-15-1393-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/0ab0733a76a2/IJGM-15-1393-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/9837d9580b07/IJGM-15-1393-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/5a5c1935b763/IJGM-15-1393-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/3259993451fb/IJGM-15-1393-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/0ab0733a76a2/IJGM-15-1393-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/9837d9580b07/IJGM-15-1393-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d6/8843352/5a5c1935b763/IJGM-15-1393-g0004.jpg

相似文献

1
Expression and Clinical Values of Serum miR-155 and miR-224 in Chinese Patients with HCV Infection.血清miR-155和miR-224在中国丙型肝炎病毒感染患者中的表达及临床价值
Int J Gen Med. 2022 Feb 10;15:1393-1403. doi: 10.2147/IJGM.S344345. eCollection 2022.
2
Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.循环miRNA-122、miRNA-199a和miRNA-16作为埃及慢性丙型肝炎病毒感染患者肝细胞癌早期检测的生物标志物。
Mol Diagn Ther. 2015 Aug;19(4):213-20. doi: 10.1007/s40291-015-0148-1.
3
Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.血清微小RNA检测板作为丙型肝炎病毒感染基础上早期检测肝细胞癌的潜在生物标志物。
Tumour Biol. 2016 Sep;37(9):12273-12286. doi: 10.1007/s13277-016-5097-8. Epub 2016 Jun 6.
4
Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.循环 miR-182 和 miR-150 作为埃及丙型肝炎病毒感染后肝硬化和肝细胞癌生物标志物的作用。
Virus Res. 2018 Aug 15;255:77-84. doi: 10.1016/j.virusres.2018.07.004. Epub 2018 Jul 9.
5
Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.在埃及患者的 HCV 诱导的肝细胞癌中肝脏特异性循环 microRNAs 的表达分析。
Cancer Biol Ther. 2018 May 4;19(5):400-406. doi: 10.1080/15384047.2018.1423922. Epub 2018 Feb 16.
6
Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.血清 microRNA 表达谱分析鉴定出与 HCV 相关的肝细胞癌的血清生物标志物。
Cancer Biomark. 2019;26(4):501-512. doi: 10.3233/CBM-181970.
7
Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.埃及患者中与丙型肝炎病毒相关的慢性肝病临床谱系中的循环微小RNA(miR-21、miR-223、miR-885-5p)
Arab J Gastroenterol. 2019 Dec;20(4):198-204. doi: 10.1016/j.ajg.2019.11.003. Epub 2019 Dec 2.
8
Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.循环微小RNA检测 panel 作为鉴别丙型肝炎病毒相关肝细胞癌的诊断工具
Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):e51-e62. doi: 10.1016/j.clinre.2017.06.004. Epub 2017 Jul 24.
9
Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma.循环 microRNA-301 作为丙型肝炎病毒相关肝细胞癌有前途的诊断生物标志物。
Mol Biol Rep. 2019 Dec;46(6):5759-5765. doi: 10.1007/s11033-019-05009-w. Epub 2019 Aug 30.
10
Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.血清 miRNA-27a 和 miRNA-18b 作为丙型肝炎病毒相关肝细胞癌的潜在预测生物标志物。
Mol Cell Biochem. 2018 Oct;447(1-2):125-136. doi: 10.1007/s11010-018-3298-8. Epub 2018 Feb 17.

引用本文的文献

1
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions.病毒性肝炎向肝细胞癌的恶性转化:机制与干预措施
MedComm (2020). 2025 Mar 8;6(3):e70121. doi: 10.1002/mco2.70121. eCollection 2025 Mar.
2
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis.miR-155在癌症中的诊断和预后价值:一项更新的荟萃分析。
Mol Diagn Ther. 2023 May;27(3):283-301. doi: 10.1007/s40291-023-00641-6. Epub 2023 Mar 20.

本文引用的文献

1
Hepatitis C Virus Infection: What Are We Currently Doing in Latin America About WHO's Proposals for 2030?丙型肝炎病毒感染:关于世界卫生组织2030年的提议,我们拉丁美洲目前正在做些什么?
Clin Liver Dis (Hoboken). 2021 Sep 19;18(2):72-75. doi: 10.1002/cld.1084. eCollection 2021 Aug.
2
Deep analysis of the LRTOMTc.242G>A variant in non-syndromic hearing loss North African patients and the Berber population: Implications for genetic diagnosis and genealogical studies.对北非非综合征性听力损失患者和柏柏尔人群中 LRTOMTc.242G>A 变体的深入分析:对遗传诊断和系谱研究的意义。
Mol Genet Genomic Med. 2021 Oct;9(10):e1810. doi: 10.1002/mgg3.1810. Epub 2021 Sep 13.
3
Expression of miR-155 and miR-146a in the saliva of patients with periodontitis and its clinical value.
miR-155和miR-146a在牙周炎患者唾液中的表达及其临床价值。
Am J Transl Res. 2021 Jun 15;13(6):6670-6677. eCollection 2021.
4
Genetics and meta-analysis of recessive non-syndromic hearing impairment and Usher syndrome in Maghreb population: lessons from the past, contemporary actualities and future challenges.马格里布人群隐性非综合征性听力损失和Usher综合征的遗传学与荟萃分析:过去的经验教训、当代现状及未来挑战
Hum Genet. 2022 Apr;141(3-4):583-593. doi: 10.1007/s00439-021-02314-y. Epub 2021 Jul 15.
5
Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population.导致突尼斯人群耳聋的基因和变异的新型致病性突变及进一步的临床相关性证据。
J Adv Res. 2021 Jan 12;31:13-24. doi: 10.1016/j.jare.2021.01.005. eCollection 2021 Jul.
6
Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma.在一组感染丙型肝炎病毒且有或无肝细胞癌的埃及患者中,研究细胞毒性T淋巴细胞相关抗原4(CTLA4)与肿瘤抑制因子RASSF1A之间的关系以及信号转导和转录激活因子4(STAT4)可能的介导作用。
Arch Virol. 2021 Jun;166(6):1643-1651. doi: 10.1007/s00705-021-04981-8. Epub 2021 Apr 1.
7
Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.FXR 的激活可调节 NASH 依赖性肝癌动物模型中的 SOCS3/Jak2/STAT3 信号通路。
Biochem Pharmacol. 2021 Apr;186:114497. doi: 10.1016/j.bcp.2021.114497. Epub 2021 Mar 4.
8
Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma.循环 miR-221 和 miR-542 表达谱作为丙型肝炎病毒介导的肝硬化和肝细胞癌的潜在分子生物标志物。
Virus Res. 2021 Apr 15;296:198341. doi: 10.1016/j.virusres.2021.198341. Epub 2021 Feb 16.
9
SRD5A3-CDG: 3D structure modeling, clinical spectrum, and computer-based dysmorphic facial recognition.SRD5A3-CDG:3D 结构建模、临床谱和基于计算机的畸形面部识别。
Am J Med Genet A. 2021 Apr;185(4):1081-1090. doi: 10.1002/ajmg.a.62065. Epub 2021 Jan 6.
10
miR-224 targets and promotes cell migration and invasion in colorectal cancer.微小RNA-224靶向并促进结直肠癌中的细胞迁移和侵袭。
3 Biotech. 2020 Nov;10(11):485. doi: 10.1007/s13205-020-02477-x. Epub 2020 Oct 24.